Scottsdale 9/24/2012 10:20:00 PM
News / Finance

Dynatronics (DYNT) Introduces New SolarisPlus Product Line

QualityStocks would like to highlight Dynatronics Corporation (NASDAQ: DYNT), engaged in the design, manufacture, distribution, and marketing of physical medicine and aesthetic products in the United States. The company offers physical medicine products, including electrotherapy, therapeutic ultrasound, infrared light therapy, oscillation therapy, iontophoresis, and vibration therapy; medical supply and soft goods products, including hot packs, cold packs, exercise balls, therapy wraps, wrist splints, ankle weights, lumbar supports, cervical collars, slings, cervical pillows, back cushions, weight racks, and parallel bars.

In the company’s news last week,

Dynatronics announced the introduction of its new line of Dynatron SolarisPlus products, which has been the result of a research and development initiative spanning three years. Four separate units make up the SolarisPlus product line: the SolarisPlus 709, 708, 706, and 705. These pioneering devices can provide seven waveforms of electrotherapy, as well as delivering Dynatronics’ patented three frequency ultrasound therapy and light therapy through a newly designed Tri-wave light probe and two light pads.

The company believes the Dynatron SolarisPlus units, its flagship products, are the most advanced devices of their kind on the market, representing the most powerful and versatile units available for the company’s practitioners and their patients.

The new, cutting-edge Tri-wave technology is comprised of red, infrared, and blue-wavelength light, delivered by means of two proprietary light pads for treating larger areas of the body or a light probe for treating smaller areas. The Tri-wave pads and light probes are substantially more powerful than their predecessors, offering a greater degree of flexibility in patient treatments. The Tri-wave devices have the capability of delivering seven different combinations of light therapy wavelengths, which enables practitioners to select the optimal treatment for each patient.

The SolarisPlus units can be mounted on a customized cart for easy transportation between clinic treatment stations. The new cart will be available in October.

The new SolarisPlus product line represents Dynatronics’ most comprehensive redesign project to date, updating the Solaris line that was originally introduced in 2003. The company anticipates the new products will stimulate higher sales of capital equipment.

Dynatronics is a manufacturer, marketer, and distributor of advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables, and rehabilitation equipment for the markets of physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology, and other related medical, cosmetic, and aesthetic fields. 

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net 

Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net  

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.